Skip to main content
. 2024 Oct 28;14:25798. doi: 10.1038/s41598-024-76630-4

Fig. 2.

Fig. 2

The baseline concentrations of MR-pro-ADM in patients with dyspnea and subjects without dyspnea measured at hospital admission (visit 1 - before treatment). *p value between levels of MR-pro-ADM before therapy in patients with and without dyspnea p = 0.015.